vasoactive intestinal peptide (VIP) in plasma

Indications

• evaluation of neuroendocrine tumors
  • VIPoma
  • neural crest tumors
  • neuroblastoma
  • MEN-1
  • pheochromcytoma
  • medullary thyroid carcinoma
  • bronchogenic carcinoma

Increases

• > 75 pg/mL in patients with VIPoma

More general terms

• vasoactive intestinal peptide (VIP) in body fluid

Additional terms

• vasoactive intestinal polypeptide (VIP); [precursor contains: intestinal peptide PHV-42; intestinal peptide PHM-27; peptide histidine methioninamide 27; vasoactive intestinal peptide]